ENvue Medical annual operating margin
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
ENvue Medical's operating margin was −896.55% for fiscal 2025.
View full ENvue Medical company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −896.55% | −756.52 pp |
| 2024 | 2024-12-31 | −140.03% | +10.47 pp |
| 2023 | 2023-12-31 | −150.50% | +515.99 pp |
| 2022 | 2022-12-31 | −666.49% | −331.21 pp |
| 2021 | 2021-12-31 | −335.28% | +422.18 pp |
| 2020 | 2020-12-31 | −757.46% | +214.42 pp |
| 2019 | 2019-12-31 | −971.89% | +381.26 pp |
| 2018 | 2018-12-31 | −1,353.14% | −59.84 pp |
| 2017 | 2017-12-31 | −1,293.31% | −281.95 pp |
| 2016 | 2016-12-31 | −1,011.35% | −42.65 pp |
| 2015 | 2015-12-31 | −968.71% | −372.16 pp |
| 2014 | 2014-12-31 | −596.55% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −2,290.38% | −1485.52 pp |
| Q1 2026 | 2026-03-31 | −568.30% | −387.62 pp |
| Q4 2025 | 2025-12-31 | −4,748.08% | −4439.52 pp |
| Q3 2025 | 2025-09-30 | −311.22% | −53.24 pp |
| Q2 2025 | 2025-06-30 | −804.86% | −722.36 pp |
| Q1 2025 | 2025-03-31 | −180.68% | −119.01 pp |
| Q4 2024 | 2024-12-31 | −308.56% | −248.92 pp |
| Q3 2024 | 2024-09-30 | −257.98% | −111.69 pp |
| Q2 2024 | 2024-06-30 | −82.50% | +260.70 pp |
| Q1 2024 | 2024-03-31 | −61.67% | +236.35 pp |
| Q4 2023 | 2023-12-31 | −59.64% | +892.93 pp |
| Q3 2023 | 2023-09-30 | −146.29% | +115.16 pp |
| Q2 2023 | 2023-06-30 | −343.20% | +65.63 pp |
| Q1 2023 | 2023-03-31 | −298.02% | +25.85 pp |
| Q3 2022 | 2022-09-30 | −952.58% | −778.63 pp |
| Q2 2022 | 2022-06-30 | −261.44% | +50.19 pp |
| Q1 2022 | 2022-03-31 | −408.82% | +866.90 pp |
| Q4 2021 | 2021-12-31 | −323.87% | +1387.24 pp |
| Q3 2021 | 2021-09-30 | −173.95% | +362.05 pp |
| Q2 2021 | 2021-06-30 | −311.64% | +234.09 pp |
| Q1 2021 | 2021-03-31 | −1,275.73% | −480.11 pp |
| Q4 2020 | 2020-12-31 | −1,711.11% | −286.97 pp |
| Q3 2020 | 2020-09-30 | −536.00% | +249.15 pp |
| Q2 2020 | 2020-06-30 | −545.72% | −205.04 pp |
| Q1 2020 | 2020-03-31 | −795.61% | +2018.31 pp |
| Q4 2019 | 2019-12-31 | −1,424.14% | +1052.23 pp |
| Q3 2019 | 2019-09-30 | −785.15% | +1670.41 pp |
| Q2 2019 | 2019-06-30 | −340.68% | +284.32 pp |
| Q1 2019 | 2019-03-31 | −2,813.92% | −1787.95 pp |
| Q4 2018 | 2018-12-31 | −2,476.36% | −1024.94 pp |
| Q3 2018 | 2018-09-30 | −2,455.56% | −1512.48 pp |
| Q2 2018 | 2018-06-30 | −625.00% | +644.23 pp |
| Q1 2018 | 2018-03-31 | −1,025.97% | +516.33 pp |
| Q4 2017 | 2017-12-31 | −1,451.43% | +264.90 pp |
| Q3 2017 | 2017-09-30 | −943.08% | −49.63 pp |
| Q2 2017 | 2017-06-30 | −1,269.23% | −533.75 pp |
| Q1 2017 | 2017-03-31 | −1,542.31% | −710.73 pp |
| Q4 2016 | 2016-12-31 | −1,716.33% | −536.84 pp |
| Q3 2016 | 2016-09-30 | −893.44% | −48.44 pp |
| Q2 2016 | 2016-06-30 | −735.48% | +72.21 pp |
| Q1 2016 | 2016-03-31 | −831.58% | +240.83 pp |
| Q4 2015 | 2015-12-31 | −1,179.49% | −856.19 pp |
| Q3 2015 | 2015-09-30 | −845.00% | +1227.00 pp |
| Q2 2015 | 2015-06-30 | −807.69% | −388.94 pp |
| Q1 2015 | 2015-03-31 | −1,072.41% | — |
| Q4 2014 | 2014-12-31 | −323.30% | — |
| Q3 2014 | 2014-09-30 | −2,072.00% | — |
| Q2 2014 | 2014-06-30 | −418.75% | — |
Over the last five reported fiscal years, ENvue Medical's operating margin decreased from −757.46% to −896.55%, a change of −139.09 percentage points. The latest reported quarter, Q2 2026, shows −2,290.38%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ENvue Medical filings at SEC.gov ↗